Regulatory Aspects of Pharmaceuticals’ Exports in Gulf Cooperation Council Countries

The Gulf cooperation council (GCC) region is considered as “Emerging market” for pharmaceutical export and bilateral trade. The understanding of the regulatory requirements of this region can be beneficial for pharmaceutical export. Some incidents of the year 2008-09, like recession or economic slow...

Descripción completa

Detalles Bibliográficos
Autores principales: Pateriya, S, Janodia, MD, Deshpande, PB, Ligade, VS, Talole, KB, Kulshrestha, T, Kamariya, Y, Musmade, PB, Udupa, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Pharmaceutical Marketing and Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122046/
https://www.ncbi.nlm.nih.gov/pubmed/21731362
http://dx.doi.org/10.4103/0975-1483.80305
Descripción
Sumario:The Gulf cooperation council (GCC) region is considered as “Emerging market” for pharmaceutical export and bilateral trade. The understanding of the regulatory requirements of this region can be beneficial for pharmaceutical export. Some incidents of the year 2008-09, like recession or economic slowdown in highly well-off and regulated market of the EU and US, raised the demand for alternate destinations for business. The regulations of Gulf countries are encouraging the import of quality generic products, which can be good news to the Indian drug manufacturers.

Ejemplares similares